Related references
Note: Only part of the references are listed.Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer
Chengcheng Gai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis
Hulya Bayir et al.
CELL CHEMICAL BIOLOGY (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Gloria V. Echeverria et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Drug Safety Evaluation in China
Lisha Li et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2019)
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Yilong Zou et al.
NATURE COMMUNICATIONS (2019)
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
Gloria E. Villalpando-Rodriguez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
A Dual Role of Heme Oxygenase-1 in Cancer Cells
Shih-Kai Chiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Ling-Chu Chang et al.
CANCER LETTERS (2018)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
Behrouz Hassannia et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Traditional Chinese herbal injection: Current status and future perspectives
Haona Li et al.
FITOTERAPIA (2018)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
D. Chen et al.
ONCOGENE (2017)
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Wanjun Lin et al.
SCIENTIFIC REPORTS (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha
Wanjun Lin et al.
PHARMACOLOGICAL RESEARCH (2016)
Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
Min-Young Kwon et al.
ONCOTARGET (2015)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Flow cytometry measurement of the labile iron pool in human hematopoietic cells
Eugenia Prus et al.
CYTOMETRY PART A (2008)
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Karen T. Liby et al.
NATURE REVIEWS CANCER (2007)
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death
CP Baines et al.
NATURE (2005)